0000899243-19-027034.txt : 20191108
0000899243-19-027034.hdr.sgml : 20191108
20191108191944
ACCESSION NUMBER: 0000899243-19-027034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191106
FILED AS OF DATE: 20191108
DATE AS OF CHANGE: 20191108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Degnan Chris
CENTRAL INDEX KEY: 0001741968
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39114
FILM NUMBER: 191205360
MAIL ADDRESS:
STREET 1: C/O VERRICA PHARMACEUTICALS INC.
STREET 2: 10 NORTH HIGH STREET, SUITE 200
CITY: WEST CHESTER
STATE: PA
ZIP: 19380
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Galera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563577
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461454898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 LINDENWOOD DRIVE
STREET 2: SUITE 405
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 610-725-1500
MAIL ADDRESS:
STREET 1: 101 LINDENWOOD DRIVE
STREET 2: SUITE 405
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-11-06
0
0001563577
Galera Therapeutics, Inc.
GRTX
0001741968
Degnan Chris
C/O GALERA THERAPEUTICS, INC.,
2 W LIBERTY BLVD #100
MALVERN
PA
19355
0
1
0
0
Chief Financial Officer
Stock Option
12.00
2019-11-06
4
A
0
229513
0.00
A
2029-11-05
Common Stock
229513
229513
D
The options vests and becomes exercisable with respect to 25% on October 21, 2020 with the remaining shares vesting and becoming exercisable in equal monthly installments over a three year period thereafter.
By: /s/ J. Mel Sorensen, Attorney-in-Fact
2019-11-08